GR1004660B - Βελτιωμενες φαρμακευτικες συνθεσεις του τριυδρικου αλενδρονικου νατριου και μεθοδοι παρασκευης τους - Google Patents
Βελτιωμενες φαρμακευτικες συνθεσεις του τριυδρικου αλενδρονικου νατριου και μεθοδοι παρασκευης τουςInfo
- Publication number
- GR1004660B GR1004660B GR20030100275A GR2003100275A GR1004660B GR 1004660 B GR1004660 B GR 1004660B GR 20030100275 A GR20030100275 A GR 20030100275A GR 2003100275 A GR2003100275 A GR 2003100275A GR 1004660 B GR1004660 B GR 1004660B
- Authority
- GR
- Greece
- Prior art keywords
- advanced
- pharmaceutical compositions
- alendronate sodium
- preparation methods
- sodium trihydrate
- Prior art date
Links
- OGSPWJRAVKPPFI-UHFFFAOYSA-N Alendronic Acid Chemical compound NCCCC(O)(P(O)(O)=O)P(O)(O)=O OGSPWJRAVKPPFI-UHFFFAOYSA-N 0.000 title abstract 2
- 229960004343 alendronic acid Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 abstract 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 abstract 1
- 229930195725 Mannitol Natural products 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 238000007908 dry granulation Methods 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 235000010355 mannitol Nutrition 0.000 abstract 1
- 239000000594 mannitol Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- PAYGMRRPBHYIMA-UHFFFAOYSA-N sodium;trihydrate Chemical compound O.O.O.[Na] PAYGMRRPBHYIMA-UHFFFAOYSA-N 0.000 abstract 1
- 239000007921 spray Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
παρούσα εφεύρεση βρίσκει εφαρμογή στην τυποποίηση δισκίων, που περιλαμβάνουν μια θεραπευτικώς δραστική ποσότητα τριϋδρικού αλλεννδρονικού νατρίου (τριϋδρικού μετά νατρίου άλατος του 4-άμινο-1-υδροξυβουτυλιδενο-1,1-διφωσφονικού οξέος) ως δραστικό συστατκό και spray dried μαλτόζη ή μαννιτόλη σε συνδυασμό με crospovidone και στεατικό ασβέστιο, καθώς και μία μέθοδο για την παρασκευήτους με διαδικασία ξηρής κοκκοποίησης. ΰ
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20030100275A GR1004660B (el) | 2003-06-25 | 2003-06-25 | Βελτιωμενες φαρμακευτικες συνθεσεις του τριυδρικου αλενδρονικου νατριου και μεθοδοι παρασκευης τους |
| ES04386021T ES2314358T3 (es) | 2003-06-25 | 2004-06-17 | Composiciones farmaceuticas de alendronato sodico trihidratado y procedimiento para la preparacion de las mismas. |
| PT04386021T PT1491199E (pt) | 2003-06-25 | 2004-06-17 | Composições farmacêuticas de alendronato de sódio tri-hidratado e processo para a sua preparação |
| EP04386021A EP1491199B1 (en) | 2003-06-25 | 2004-06-17 | Pharmaceutical compositions of alendronate sodium trihydrate and process for the preparation thereof |
| AT04386021T ATE407680T1 (de) | 2003-06-25 | 2004-06-17 | Pharmazeutische zubereitung von alendronat natrium trihydrat und verfahren deren herstellung |
| DE602004016419T DE602004016419D1 (de) | 2003-06-25 | 2004-06-17 | Pharmazeutische Zubereitung von Alendronat Natrium Trihydrat und Verfahren deren Herstellung |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20030100275A GR1004660B (el) | 2003-06-25 | 2003-06-25 | Βελτιωμενες φαρμακευτικες συνθεσεις του τριυδρικου αλενδρονικου νατριου και μεθοδοι παρασκευης τους |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR1004660B true GR1004660B (el) | 2004-08-25 |
Family
ID=33187103
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR20030100275A GR1004660B (el) | 2003-06-25 | 2003-06-25 | Βελτιωμενες φαρμακευτικες συνθεσεις του τριυδρικου αλενδρονικου νατριου και μεθοδοι παρασκευης τους |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1491199B1 (el) |
| AT (1) | ATE407680T1 (el) |
| DE (1) | DE602004016419D1 (el) |
| ES (1) | ES2314358T3 (el) |
| GR (1) | GR1004660B (el) |
| PT (1) | PT1491199E (el) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006046100A1 (en) * | 2004-10-25 | 2006-05-04 | Ranbaxy Laboratories Limited | Pharmaceutical composition of alendronic acid |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0616794D0 (en) | 2006-08-24 | 2006-10-04 | Arrow Int Ltd | Solid dosage form |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000511178A (ja) * | 1996-05-17 | 2000-08-29 | メルク エンド カンパニー インコーポレーテッド | 発泡性ビスホスホネート製剤 |
-
2003
- 2003-06-25 GR GR20030100275A patent/GR1004660B/el not_active IP Right Cessation
-
2004
- 2004-06-17 AT AT04386021T patent/ATE407680T1/de not_active IP Right Cessation
- 2004-06-17 EP EP04386021A patent/EP1491199B1/en not_active Expired - Lifetime
- 2004-06-17 PT PT04386021T patent/PT1491199E/pt unknown
- 2004-06-17 DE DE602004016419T patent/DE602004016419D1/de not_active Expired - Fee Related
- 2004-06-17 ES ES04386021T patent/ES2314358T3/es not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006046100A1 (en) * | 2004-10-25 | 2006-05-04 | Ranbaxy Laboratories Limited | Pharmaceutical composition of alendronic acid |
Also Published As
| Publication number | Publication date |
|---|---|
| ATE407680T1 (de) | 2008-09-15 |
| DE602004016419D1 (de) | 2008-10-23 |
| PT1491199E (pt) | 2008-12-12 |
| ES2314358T3 (es) | 2009-03-16 |
| EP1491199B1 (en) | 2008-09-10 |
| EP1491199A1 (en) | 2004-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY142046A (en) | Rapid dissolution formulation of a calcium receptor-active compound | |
| HRP20120803T1 (hr) | Prolijekovi alkilatora fosforamidata | |
| NO20076675L (no) | Aminopiperidinquinoliner og deres azaisosteriske analoger med antibakteriell aktivitet | |
| BR0312573A (pt) | Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina | |
| ECSP055688A (es) | Nuevas formulaciones farmacéuticas sólidas que comprenden telmisartano y su preparación | |
| MX2009003184A (es) | Composiciones farmaceuticas que comprenden nilotinib o su sal. | |
| UA99136C2 (ru) | Улучшенная фармацевтическая композиция, содержащая антагонист кальциевых каналов - лерканидипин, способ ее получения | |
| MY162319A (en) | Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer | |
| NO20075111L (no) | Farmasoytisk sammensetning | |
| AR044200A1 (es) | Composicion de fondaparinux sodico de alta pureza ,un procedimiento de preparacion de esta composicion y composiciones farmaceuticas que la contienen como principio activo | |
| WO2008116601A3 (en) | Solid dosage forms comprising aliskiren and pharmaceutically acceptable salts thereof | |
| ZA201003380B (en) | Improved pharmaceutical composition containing a pyrrolidone anticonvulsant agent and methhod for the preparation thereof | |
| EA200602175A1 (ru) | Агломерация кальцийсодержащего соединения прессованием на валках | |
| WO2007134158A3 (en) | Granules comprising calcium carbonate, a binder and a porosity increasing agent, processes of manufacturing, use in therapy | |
| WO2009049648A3 (en) | Improved pharmaceutical composition containing antiviral agent and method for the preparation thereof | |
| GR20070100405A (el) | Βελτιωμενες φαρμακοτεχνικες μορφες που περιεχουν αναστολεις της ακετυλοχοληνεστερασης και μεθοδοι παρασκευης αυτων | |
| TW200640933A (en) | Anthelmintic compounds | |
| UA95274C2 (ru) | Твердый фармацевтический препарат, содержащий ирбесартан, и способы его изготовления | |
| PT1473029E (pt) | Forma de dosagem solida compreendendo desmopressina | |
| GB0403606D0 (en) | Organic compounds | |
| PT1818048E (pt) | Formulações farmacêuticas de polímeros aminados alifáticos e processos para a sua produção | |
| BRPI0508767A (pt) | composição que apresenta palatabilidade aprimorada, partìculas secas por congelamento peneiradas, partìculas secas por congelamento semelhantes a pó comprimìvel e de livre fluxo, processo para fabricar as mesmas, composições farmacêuticas com palatabilidade aprimorada, método para fabricar as mesmas e método para fabricar comprimidos | |
| TW200720239A (en) | Styrylsulfonamides, their manufacture and use as pharmaceutical agents | |
| ZA200706705B (en) | Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof | |
| WO2007025764A3 (de) | Pharmazeutische formulierung für salze monobasischer säuren mit clopidogrel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ML | Lapse due to non-payment of fees |
Effective date: 20170109 |